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Genetics of common progressive renal disease. Familial aggre-
gation of common chronic kidney diseases provides a unique
opportunity to investigate the susceptibility genetic and envi-
ronmental factors. In the past decade, a wealth of new data has
become available concerning the genetic susceptibility leading
to numerous nephropathies. Knowledge of the genetic compo-
nents allows better understanding of initiation and progression
of these chronic kidney diseases. In addition, one can envision
that identification of genetically susceptible individuals might
lead to earlier diagnosis and potential reversal of the current
epidemic of end-stage renal disease. The goal of the current
discussion is to review various issues pertaining to the role of ge-
netic factors in common chronic kidney diseases, as exemplified
by two leading causes of end-stage renal diseases worldwide,
nephropathy of type 2 diabetes and IgA nephropathy. The ge-
netic and environmental interplay leading to the nephropathies
is highlighted.
In the simplest monogenic renal disorders (such as
X-linked Alport syndrome, X-linked Anderson-Fabry
disease, autosomal-recessive cystinosis, and autosomal-
dominant polycystic kidney disease), much has been un-
raveled and learned regarding the clearly genetic forms
secondary to single gene disorders. A more perplexing
question concerning the vast majority of common kid-
ney diseases relates to their complex genetic components,
which interact with environmental risk factors [1].
In the post-genome era, studies deciphering the human
genome have contributed to the understanding of multi-
factorial kidney diseases, which are probably in part ge-
netically determined, despite the heterogeneity in their
genetic susceptibility and disease penetrance. Three of
the most important study tools [1, 2] are family clus-
tering reports, candidate gene case control association
studies, and genome screen analysis (or linkage analy-
sis). The purpose of this review is to give an overview
of current research in genetic studies of common kid-
ney diseases, and in particular, focus on two common and
exemplary entities—nephropathy of type 2 diabetes and
IgA nephropathy. At present, these two renal disorders
account for the vast majority of end-stage renal disease
burden. Furthermore, description of these two examples
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can be generalized to genetic research of other kidney
diseases.
GENETICS OF TYPE II DIABETIC
NEPHROPATHY
Much has been learned about the genetic predisposi-
tion of diabetic nephropathy in type 1 diabetes mellitus
[3, 4]. The possible genetic role in kidney complication
in both type 1 and 2 diabetes mellitus was suggested in
the Diabetes Control and Complications Trial (DCCT)
[5], while increasing evidence has suggested genetic fac-
tors in the development of renal disease in type 2 dia-
betes. Genetic basis of diabetic nephropathy was further
supported by the observation that up to 35% of patients
develop nephropathy irrespective of glycemic control [6].
Family clustering reports
The best evidence of familial predisposition of renal
disease in type 2 diabetes was perhaps derived from
the Pima Indians, among whom proteinuria occurred in
45.9% if both parents had diabetes and proteinuria com-
pared to 14.3% of offspring if neither parent had pro-
teinuria [7]. Obviously, it would have been difficult, if not
impossible, to replicate such results in other populations
[8, 9, 10], where the incidence of type 2 diabetes melli-
tus is much lower and the age onset of diabetes is much
later. Furthermore, given the sharing of many environ-
mental factors apart from genetic ones [1, 11], evidence
of familial aggregation of diabetic nephropathy alone is
insufficient.
Candidate gene studies
The candidate gene approach has been used by various
groups to study nephropathy of type 2 diabetes mellitus.
Briefly, this involves selection of specific genes based on a
function that could be closely related to and/or causative
of kidney disease. Alternatively, the premise of candi-
date gene selection was determined by direct empirical
evidence that the gene product is associated with diabetic
nephropathy [2].
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Table 1. Putative candidate genes and potential loci with possible association with nephropathy of type 2 diabetes
Chromosome Gene variant or locus Putative association Reference
17 Angiotensin-converting enzyme insertion/deletion
polymorphism
Diabetic nephropathy in Japanese and possibly
Asians
[14, 15, 17, 18]
7 Plasminogen activator inhibitor-1 4G/4G
polymorphism
Diabetic nephropathy in Chinese population,
possible synergistic effect with ACE D allele
[19]
18 Transforming growth factor-beta T869C (Leu10Pro)
polymorphism
Diabetic nephropathy in Chinese population [21]
3q, 7q, 18q, 20p Unknown, possibly 18q22.3–23 between markers
D18S469 and D18S58
Diabetic nephropathy in Pima Indians and Turkish
population
[24, 25]
The results from candidate gene approach are hith-
erto conflicting. This has been illustrated by the stud-
ies of renin-angiotensin system genetic polymorphism.
Among them, the gene coding for angiotensin-converting
enzyme, in which an insertion/deletion polymorphism has
been described, received special attention owing to its
cardinal role in renal hemodynamics, sodium metabolism,
and cardiovascular morbidity [12]. We have previously
examined the role of angiotensin-converting enzyme
ACE/ID polymorphism in a cohort of Chinese patients
with type 2 diabetes [13]. There was no difference in the
distribution of polymorphisms between patients with and
without nephropathy, which stands at odds with the find-
ings that ACE/DD genotype was associated with the pro-
gression of diabetic nephropathy in Japanese [14, 15]. The
discrepancy in the published literature obliges us to con-
sider the possibility of heterogenous case definition and
control selection, variation in power between studies, im-
pact of varying allelic frequencies, heterogeneity in effect
size of ACE/ID polymorphism, as well as ethnicity [16].
In fact, subsequent meta-analysis and systemic reviews
suggested a possible role of the ACE/ID polymorphisms
in diabetic nephropathy in Japanese [17], but not Cau-
casians [17, 18].
Recently, we have further examined the role of plas-
minogen activator inhibitor-1 (PAI-1) gene polymor-
phisms in the development of nephropathy of type 2
diabetes. In a cohort of Chinese population, the PAI-1
4G/4G genotype was found to be an independent risk fac-
tor of developing diabetic nephropathy (odds ratio 1.85,
95% confidence interval 1.35 to 2.15). Most intriguing,
a synergistic effect of the PAI 4G/4G genotype and the
ACE D allele was noted [19]. Our observation reflects an
interaction of PAI-1 and renin-angiotensin system. This
is a good example of complex trait disease in which gene-
gene interactions or effect modification by other genetic
factors could occur, not to mention the interplay of envi-
ronmental factors. With multivariate analysis, the only in-
dependent predictors for diabetic nephropathy are PAI-1
4G4G genotype (odds ratio 1.9, 95% confidence interval
1.4 to 2.2) and the presence of hypertension (odds ratio
2.8, 95% confidence interval 2.3 to 3.2) [19].
Most important of all, even the apparently significant
findings of PAI-1 and ACE D/I polymorphism were con-
sistent with an existing biologically plausible hypothesis,
and an initial finding of association needs to be replicated
in an independent population [16, 20]. The same applies
to other candidate gene in various cytokine cascades or
growth factors, such as our recent finding of association
between nephropathy of type 2 diabetes and transform-
ing growth factor-beta (TGF-b) T869C (Leu10Pro) poly-
morphism [21], which correlates with circulating TGF-b
levels.
Table 1 illustrates some of the reported candidate genes
in human diabetic nephropathy.
Genome screen
Unless a functional polymorphism can be identified
in advance, detection of genetic loci would rely on the
genome-wide screen or linkage analysis. In short, for com-
mon diseases like diabetic nephropathy, only a few genes
are likely to contribute to its occurrence; based on recent
estimations, two to three genes are likely to be involved
in the pathogenesis of diabetic nephropathy.
Aided by high-throughput technologies, large-scale
genome-wide screen can now be accomplished to nar-
row down the susceptibility locus of diabetic nephropa-
thy by linkage analysis of families with multiple affected
members [22]. In statistical terms, an estimate of the asso-
ciation between a genetic loci and a disease is expressed
by the likelihood-of-odds (LOD) score. The score repre-
sents the log10 of the odds that the marker and disease
phenotype are linked at a particular recombination frac-
tion compared with the odds that the loci are unlinked.
In practice, a LOD score of 3 (1000:1 odds in favor of
linkage) or more is generally taken as proof of linkage.
The most robust study design today is thought to be the
affected sib pairs nonparametric linkage analyses [23].
According to tentative evidence from a sib-pair linkage
analysis on 98 Pima Indian diabetic sibling pairs [24] and
18 large Turkish families [25], diabetic nephropathy sus-
ceptibility loci were probably located on chromosomes
3q, 7q, 18q, and 20p, with LOD scores ranging between
1.28 and 6.1. An ongoing multicenter genome-wide link-
age analysis will further shed light on the gene(s) respon-
sible for diabetic nephropathy [26]. Until now, the sample
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size in most genetic linkage studies of diabetic nephropa-
thy has remained small [23, 27, 28].
Last, but not the least, despite the mounting epidemi-
ologic study evidence for its genetic basis, our search for
the underlying genetic factors of diabetic kidney disease
has been limited by the lack of an appropriate animal
model of type 2 diabetic nephropathy. Recent success
with developing such a rodent model [29] might provide
a new paradigm in dissecting the complex interplay be-
tween various factors in the progression of diabetic kid-
ney disease.
GENETICS OF IMMUNOGLOBULIN A
NEPHROPATHY
Family clustering reports
Familial aggregation of IgA nephropathy is being in-
creasingly recognized [30, 31], although its precise preva-
lence and the role of genetic factors remained elusive. It is
clear, however, that descriptive reports of familial aggre-
gation of primary IgA nephropathy provide the strongest
human study evidence of genetic roles in the development
and progression of the disease [32].
Candidate gene studies
As elaborated in a comprehensive reappraisal of
the case-control genetic association studies on IgA
nephropathy [32], the earliest genetic evidence was cen-
tered on the human major histocompatibility complex
allelic variation, previously made possible by restriction
fragment length polymorphisms analysis [33, 34]. Accord-
ing to our previous case-control study, several HLA-DQ
alleles were associated with IgA nephropathy disease
progression. In particular, the allele frequency of DQa2
U allele was found to be significantly increased in those
IgA nephropathy patients with chronic renal insufficiency
[34], but the gene association will need to be confirmed
in a larger cohort.
Subsequent candidate loci association studies involved
the T-cell receptor polymorphism. This is based on the
notion that altered cellular immunity frequently occurs
in IgA nephropathy, as manifested by hyperactivity of
T helper cells. According to our case-control study on
the polymorphisms of T-cell receptor constant alpha
chain, the 7-kb Ca allele was more frequent in biopsy-
proven IgA nephropathy patients than healthy controls
[35]. Other candidate gene(s) included polymorphism of
interleukin-1 [36], although many of the results cannot
be duplicated in subsequent studies.
Genetic factors responsible for the initiation of the kid-
ney disease may differ from factors modulating the pro-
gression of the disease. With reference to the progression
of IgA nephropathy, the implicated ACE/ID polymor-
phism is even more conflicting or fragmentary than the
case in aforementioned diabetic nephropathy. Despite
positive results of early studies, a recent meta-analysis
did not support the role of ACE/ID polymorphisms in
the susceptibility or progression of IgA nephropathy [37].
Conversely, the prognosis and therapeutic response in
IgA nephropathy may be influenced by the angiotensino-
gen gene A(−20)C [38, 39] and M235T [40, 41, 42] poly-
morphism.
Evidence from case-control studies can give rise to
spurious associations [16, 32]. It has been proposed that
preliminary candidate gene identified as such should be
tested by more powerful and robust methodologies, such
as the transmission disequilibrium test. Briefly, this non-
parametric and model-free method tests for association
due to two loci being tightly linked. To test whether a
marker allele exhibits transmission disequilibrium with
IgA nephropathy, for instance, parents of affected sub-
jects are observed. If parents who are heterozygous for
the allele transmit it to affected offspring on more than
50% of occasions, this is evidence for linkage between
the marker and IgA nephropathy loci [32, 43, 44]. Recent
examples of affirmative test of candidate genes responsi-
ble for IgA nephropathy included the selectin genes [45]
and HLA-DRA [46].
Genome screen
By genome-wide analysis of linkage in 30 multiplex
IgA nephropathy kindreds [47], linkage of IgA nephropa-
thy was demonstrated in a 6.5-cM region bounded by
the D6S1702 and D6S262 polymorphic markers on chro-
mosome 6q22-23, with a maximal LOD score of 5.6
at D6S1040. Furthermore, six single-nucleotide poly-
morphisms located in the polymeric immunoglobulin
receptor gene at chromosome 1q31-q41, as tested in a
genome-wide analysis of approximately 80,000 single-
nucleotide polymorphisms, were noted to predispose
Japanese patients to develop IgA nephropathy [48].
Taken together, these robust findings (Table 2) add
weight to the existence of a locus with large effect on
development of IgA nephropathy, in combination with
environmental conditions.
CONCLUSION
The current data are consistent with the hypothesis that
genetic factors play an important role in determining sus-
ceptibility and progression of nephropathy of type 2 dia-
betes and IgA nephropathy. Uncovering genetic factors
that predispose individuals to progressive kidney diseases
would lead to improve understanding of the molecular
basis of renal disease, help identify susceptible individ-
uals, and most important of all, contribute to improving
clinical outcomes with far-reaching implications for pub-
lic health.
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Table 2. Putative candidate genes and loci associated with IgA nephropathy
Chromosome Gene variant or locus Putative association Reference
6 Histocompatibility antigen DQa2 alleles Progression of IgA nephropathy in Chinese [34]
14 T-cell receptor constant alpha chain gene polymorphism Development of IgA nephropathy in Chinese [35]
2 Interleukin-1 (IL1b2) and (IL1RN∗2) polymorphism Development of IgA nephropathy in Japan [36]
1 Angiotensinogen A(−20)C polymorphism Progression of IgA nephropathy in Japanese [38, 39]
1 Angiotensinogen M235T and A(−20)C polymorphism Progression of IgA nephropathy in Japanese and
Caucasians
[40, 41, 42]
1q E-selectin gene SELE8 and SELE13 and L-selectin gene
polymorphism
Development of IgA nephropathy in Japanese [45]
6p Histocompatibility antigen HLA-DRA gene
polymorphism
Development of IgA nephropathy in Japanese [46]
6q 6q22-23 between markers D6S1702 and D6S262 Development of IgA nephropathy in Caucasians [47]
1q Polymeric immunoglobulin receptor gene polymorphism
at 1q31-41
Development of IgA nephropathy in Japanese [48]
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